The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD (Q73002507)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Nikolova Z

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Hof A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Baumlin Y

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Hof RP

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Transplant Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

115-124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Immunosuppressive action of FTY720 for renal allograft a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

SDZ RAD, a new rapamycin derivative: synergism with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Effects of rapamycin analogue SDZ RAD on obliterative lesions in a porcine heterotopic bronchial allograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

The effect of rapamycin on kidney function in the Sprague-Dawley rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

FTY720: a new immunosuppressive agent with novel mechanism(s) of action

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Towards understanding the pathophysiology of chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

SDZ RAD inhibits cold ischemia-induced vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900016-2

7 January 2021

10.1016/S0966-3274(00)00016-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11005317%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference